Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Journal of Enzyme Inhibition
|
January 1, 1992
Reverse transcriptase--a general discussion
A L DeVico, M G Sarngadharan
Proceedings of the National Academy of Sciences of the United States of America
|
December 10, 1999
Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling
J M Burns, G K Lewis, A L DeVico
Journal of Clinical Immunology
|
August 26, 1998
Chemokine receptors and chemokines in HIV infection
A Garzino-Demo, A L DeVico, R C Gallo
Journal of Clinical Immunology
|
October 27, 1999
HIV infection and pathogenesis: what about chemokines?
R C Gallo, A Garzino-Demo, A L DeVico
AIDS Research and Human Retroviruses
|
July 22, 1998
Beta-chemokines and protection from HIV type 1 disease
A Garzino-Demo, A L DeVico, F Cocchi, et al.
Journal of Virology
|
October 17, 2001
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion
C M Finnegan, W Berg, G K Lewis, et al.
AIDS Research and Human Retroviruses
|
August 1, 1994
Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individuals
A L Devico, R Rahman, M G Sarngadharan, et al.
The Journal of Experimental Medicine
|
November 17, 1998
A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling
J M Burns, R C Gallo, A L DeVico, et al.
Immunological Reviews
|
January 4, 2001
The role of chemokines in human immunodeficiency virus infection
A Garzino-Demo, A L DeVico, K E Conant, et al.
Princess Takamatsu Symposia
|
January 1, 1984
HTLV-III: the etiologic agent of AIDS
M G Sarngadharan, A L DeVico, L Bruch, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Journal of Enzyme Inhibition
|
January 1, 1992
Reverse transcriptase--a general discussion
A L DeVico, M G Sarngadharan
Proceedings of the National Academy of Sciences of the United States of America
|
December 10, 1999
Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling
J M Burns, G K Lewis, A L DeVico
Journal of Clinical Immunology
|
August 26, 1998
Chemokine receptors and chemokines in HIV infection
A Garzino-Demo, A L DeVico, R C Gallo
Journal of Clinical Immunology
|
October 27, 1999
HIV infection and pathogenesis: what about chemokines?
R C Gallo, A Garzino-Demo, A L DeVico
AIDS Research and Human Retroviruses
|
July 22, 1998
Beta-chemokines and protection from HIV type 1 disease
A Garzino-Demo, A L DeVico, F Cocchi, et al.
Journal of Virology
|
October 17, 2001
Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion
C M Finnegan, W Berg, G K Lewis, et al.
AIDS Research and Human Retroviruses
|
August 1, 1994
Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individuals
A L Devico, R Rahman, M G Sarngadharan, et al.
The Journal of Experimental Medicine
|
November 17, 1998
A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling
J M Burns, R C Gallo, A L DeVico, et al.
Immunological Reviews
|
January 4, 2001
The role of chemokines in human immunodeficiency virus infection
A Garzino-Demo, A L DeVico, K E Conant, et al.
Princess Takamatsu Symposia
|
January 1, 1984
HTLV-III: the etiologic agent of AIDS
M G Sarngadharan, A L DeVico, L Bruch, et al.
Page
of 4